Antibrain antibodies in children with autism and their unaffected siblings

https://doi.org/10.1016/j.jneuroim.2006.05.025Get rights and content

Abstract

Serum autoantibodies to human brain, identified by ELISA and Western immunoblotting, were evaluated in 29 children with autism spectrum disorder (22 with autistic disorder), 9 non-autistic siblings and 13 controls. More autistic subjects than controls had bands at 100 kDa in caudate, putamen and prefrontal cortex (p < 0.01) as well as larger peak heights of bands at 73 kDa in the cerebellum and cingulate gyrus. Both autistic disorder subjects and their matched non-autistic siblings had denser bands (peak height and/or area under the curve) at 73 kDa in the cerebellum and cingulate gyrus than did controls (p < 0.01). Results suggest that children with autistic disorder and their siblings exhibit differences compared to controls in autoimmune reactivity to specific epitopes located in distinct brain regions.

Introduction

Autistic spectrum disorders, including autistic disorder, Asperger syndrome, high functioning autism, atypical (with genetic dysmorphic features) and a late regression form, herein called autistic spectrum disorders, are characterized by the core features of impaired socialization, impaired verbal and nonverbal communication, and restrictive patterns of behavior (Filipek et al., 1999). Autism is a common disorder of childhood affecting approximately 2 in 1000 children, with an increasing prevalence ranging from 0.6 to 4.6 per 1000 (Mandell and Palmer, 2005). Symptoms are often identified in children from 18 to 30 months of age and traits persist into adulthood with varied outcomes (Rapin, 1997).

A variety of pathophysiological mechanisms have been proposed to underlie development of autism, including genetic, biochemical and environmental causes. Despite numerous reports suggesting a high rate of inheritance, no specific single genes have been identified that are more than risk factors (Bespalova and Buxbaum, 2003, Santangelo and Tsatsanis, 2005). Prenatal environmental factors, such as obstetrical suboptimality, alcohol exposure and intrauterine infection, have also been reported to influence the occurrence of autism (Larsson et al., 2005). One additional mechanism that has received serious consideration is an abnormality of immune function.

Several lines of evidence suggest that immune factors may have a prominent role in autism. Patients with autism have clustering of autoimmune disorders in their families (Comi et al., 1999, Croen et al., 2005), evidence of immune dysregulation (Gupta, 2000) and abnormal levels of plasma immunoglobulins (Plioplys et al., 1994). Pathologically, an active neuroinflammatory process has been identified in the cerebral cortex, white matter and cerebellum of autistic patients (Vargas et al., 2005). Although the authors of the latter report focused on potential abnormalities of cytokines, other investigators have emphasized a role for autoantibodies. Multiparametric analyses of repertoires of plasma autoantibodies to human brain have shown significant differences between children with autism and controls (Silva et al., 2004). In the autistic population, serum antibodies are more prevalent against rodent caudate, cortex and cerebellum (Singh and Rivas, 2004), and antibodies have been found against specific brain proteins, e.g., glial fibrillary acidic protein and myelin basic protein (Singh et al., 1993, Singh et al., 1997). Lastly, behavioral changes have been induced in embryonic rodents after, exposure to anti-Purkinje cell antibodies from the mother of an autistic child (Dalton et al., 2003).

The goal of this study was to investigate serum autoantibodies to human brain in children with autism, their non-autistic siblings and a healthy control group. Specific brain regions were selected for inclusion on the basis of postmortem, magnetic resonance imaging and autoantibody studies in autistic patients (Ritvo et al., 1986, Bauman, 1991, Courchesne et al., 1988, Zilbovicius et al., 1995, Singh and Rivas, 2004). Enzyme-linked immunosorbent assays (ELISA) and Western immunoblotting were performed using supernatant fractions from fresh human postmortem tissue with the goal of determining reactivity against multiple antigens. It was hypothesized that, if some subtypes of autism were related to an autoantibody, affected individuals would have definable patterns on immunoblotting and possibly higher optical density readings on ELISA. Comparisons with non-autistic siblings would identify whether there were common familial autoreactivities that were unrelated to autistic pathophysiology.

Section snippets

Subjects

After informed consent was obtained, serum was collected from 29 children with autism (mean age 6.8 years, range 3–12): 22 with typical-autism (autistic disorder: IQ < 70, mean age 6.5 years, range 3–9), three with atypical autism (one each with genetic dysmorphic features, Smith-Lemli-Opitz syndrome and mitochondrial dysfunction), two with high functioning autism (IQ > 70), one with Asperger syndrome and one with late regression (childhood disintegrative disorder). Serum was also available from

Western blots for brain proteins

Western immunoblot analyses with BA10, caudate, cerebellum, cerebellar deep nuclei, cingulate gyrus and putamen identified numerous bands in all subjects (Fig. 1). Blots showed similar mean numbers of measurable antibody reactivity peaks on Quantity One images for all subject groups. No molecular weight range showed activity exclusive to a specific group for any of the brain regions. Although the number of autistic subjects in several subgroups was limited, no obvious differences among the

Discussion

The presence of autoantibodies against components of the central nervous system, serum immunoglobulin abnormalities, altered T-cell functions and abnormalities of cytokines have led investigators to hypothesize that autism may result from autoimmunity (Zimmerman, 2005). The present study of serum, in which immunoblotting and an analysis of scanned blots were examined, showed that more children with autism than controls had autoimmune complexes in the basal ganglia and frontal lobe at 100 kDa.

Acknowledgements

This research was supported in part from a National Alliance for Autism Research grant (#1213). The authors thank Pamela Talalay for her editorial review.

References (31)

  • N.M. Bornstein et al.

    Antibodies to brain antigens following stroke

    Neurology

    (2001)
  • A.M. Comi et al.

    Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism

    J. Child Neurol.

    (1999)
  • E. Courchesne et al.

    Hypoplasia of cerebellar vermal lobules VI and VII in autism

    N. Engl. J. Med.

    (1988)
  • L.A. Croen et al.

    Maternal autoimmune diseases, asthma, and allergies, and childhood autism spectrum disorders

    Arch. Pediatr. Adolesc. Med.

    (2005)
  • P. Dalton et al.

    Maternal neuronal antibodies associated with autism and a language disorder

    Ann. Neurol.

    (2003)
  • Cited by (109)

    • Autoantibody and autism spectrum disorder: A systematic review

      2020, Research in Autism Spectrum Disorders
      Citation Excerpt :

      Studies have indicated that both hyperserotoninemia and autoimmunity might be modulated by a common factor, but further exploration is required (Burgess, Sweeten, McMahon, & Fujinami, 2006). This group is represented by antibodies against brain tissue, which are identified autoantibodies against unknown antigens in the basal ganglia, prefrontal cortex, cerebellum, cingulate gyrus (Mora et al., 2009; Singer et al., 2006; Todd et al., 1988) and the Purkinje cells (Wills et al., 2009). Antibodies against 45 and 62 kDa proteins from cerebellum were found in the plasma of ASD children by immunoblotting, with antigens extracted from rhesus macaque cerebellum (Wills et al., 2009).

    View all citing articles on Scopus
    View full text